Find Resources
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Peer Review Study, Summary Report/Recommendations
The guidance outlined in this report provides a roadmap for the ethical inclusion of pregnant women’s experiences in in the development and deployment of vaccines against emerging viruses. Recommendations include bolstering health information surveillance systems, stakeholder engagement with health care, women, families and communities, and changing the narrative about pregnancy and clinical research efforts. Recommendations require commitment of financial resources, addressing inequities in public health and whenever possible, the inclusion of perspectives of pregnant women. Lastly, the authors recommend that “When there is a limited supply of vaccine against a pathogenic threat that disproportionately affects pregnant women, their offspring, or both, or when only one vaccine among several is appropriate for use in pregnancy, then pregnant women should be among the priority groups to be offered the vaccine.” This prioritization process is key to addressing inequities and are guidance for future pandemic response efforts.
Best Practices that show evidence of effectiveness in improving public health outcomes when implemented in multiple real-life settings, as indicated by achievement of aims consistent with the objectives of the activities.
RELEASE DATE:
Summary Report/Recommendations
In this report, the National Vaccine Advisory Committee (NVAC) discusses maternal immunizations best practices, as well as gaps to implementation recommendations. One recommendation includes focusing efforts to improve financing for immunization services during pregnancy and the postpartum period. Public health and health care partners can support efforts promoting new payment and delivery models, patient-centered medical homes, and accountable care organizations. NVAC also recommends partnering with professional organizations and other maternal immunization stakeholders to develop toolkits and guidance for improving processes.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This report highlights the efficacy of COVID-19 mRNA vaccines (2-dose series) for pregnant mothers and their infants. In the aftermath of the Delta and Omicron waves, infants born to unvaccinated mothers were more likely to be among those hospitalized for COVID-19.
Novel Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and are in the process of generating evidence of effectiveness or may not yet be tested.
RELEASE DATE:
Summary Report/Recommendations
This article includes commentary for public health agencies, the healthcare community, and professional schools to develop an approach to allocate the COVID-19 vaccine in a way that does not rely on health information technology as the predominant means to vaccine access. The authors notes that doing so will provide better access to medical care during the ongoing pandemic and perhaps carve out a new model that improves healthcare access after we conquer COVID-19.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Summary Report/Recommendations
This article explores how the relationships between vaccine site density, vaccination rates, and social vulnerability are connected across metropolitan and non-metropolitan areas in the U.S. The study uses CDC Social Vulnerability Index data combined with vaccination site density data to examine how vaccination site placement can benefit highly vulnerable populations. The results determined that while areas with higher socioeconomic vulnerability contain a large density of vaccination sites, this does not affect the low vaccination rates found in these communities. Other methods besides vaccination site placement must be considered to overcome these barriers in vaccination rates.